Author:
Liu Fei Fei,Bartlett Meaghan,Craigie Samantha
Publisher
Springer Science and Business Media LLC
Reference80 articles.
1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49.
2. Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology. 2018;50(1):74–87.
3. Gandhi S, Kallab AM, Hernandez-Ilizaliturri FJ. Diffuse large B-cell lymphoma (DLBCL) guidelines. 18 Nov 2022. https://emedicine.medscape.com/article/202969-guidelines. Accessed 25 Oct 2021.
4. Tilly H, Gomes da Silva M, Vitolo U, et al., on behalf of the ESMO Guidelines Committee. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(suppl 5):v116–v25.
5. Maurer MJ, Ghesquières H, Jais JP, et al. Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. J Clin Oncol. 2014;32(10):1066–73.